Tanzania has made major progress toward reducing child mortality, including achieving full domestic financing for the recommended first-line treatment for childhood pneumonia, amoxicillin dispersible tablets (Amox DT). These gains reflect years of collaboration between the Government of Tanzania and Results for Development (R4D) to strengthen markets, financing, and supply systems that ensure life-saving medicines reach health facilities.
Yet important gaps remain. Too many pneumonia cases are still not correctly diagnosed at the facility level, and access in the private sector remains limited. Addressing these challenges will be critical for sustaining progress and ensuring that more children receive timely, effective treatment.
This policy brief outlines six priority actions the Ministry of Health can take to build on recent progress, strengthen pneumonia diagnosis and treatment, and sustain access to essential medicines as Tanzania works toward its 2030 child mortality goals.
For more on the collaboration between the Government of Tanzania and R4D to expand access to childhood pneumonia treatment, see the accompanying impact brief.
Additional resources:
Implementation and lessons
- Supporting Tanzania’s Ministry of Health to improve commodity availability through bottom-up quantification
- Sustainable health commodity financing: Lessons from Tanzania’s transition from donor funding
Research and analysis
